(Q37989741)

26 August 2017

title

Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence (English)

1 reference

26 August 2017

0 references

6

Emile Darai

1 reference

26 August 2017

Philippe Morice

1

1 reference

26 August 2017

Catherine Uzan

2

1 reference

26 August 2017

Raffaele Fauvet

3

1 reference

26 August 2017

Sebastien Gouy

4

1 reference

26 August 2017

Pierre Duvillard

5

1 reference

26 August 2017

publication date

1 March 2012

1 reference

Lancet Oncology Commission

26 August 2017

published in

1 reference

26 August 2017

volume

13

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

e103-15

1 reference

Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Risk factors for recurrence of ovarian borderline tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Clinical outcome and risk factors for recurrence in borderline ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Borderline epithelial tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian endometrioid tumors of low malignant potential: a clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian serous low malignant potential (borderline) tumor--does "micropapillary" matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous borderline tumours of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Borderline ovarian tumors: key points and workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous tumours of low malignant potential (serous borderline tumours): moving toward détente

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous borderline tumors of the ovary with noninvasive peritoneal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Recurrent micropapillary serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and müllerian type.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Laparoscopic management of borderline ovarian tumors: results of a French multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Port-site implantation after laparoscopic treatment of borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

The current status of surgical staging of ovarian serous borderline tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Evaluation of surgical staging in stage I low malignant potential ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Surgical staging in patients with ovarian tumors of low malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Prognostic value of lymph node involvement in ovarian serous borderline tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Interventions for the treatment of borderline ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970288-1

7 January 2021

10.1016/S1470-2045(11)70288-1

Identifiers

DOI

1 reference

26 August 2017

1 reference